Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population

被引:8
作者
Kang, Yu Mi [1 ]
Jung, Chang Hee [1 ]
Cho, Yun Kyung [1 ]
Lee, Seung Eun [1 ]
Lee, Min Jung [2 ]
Hwang, Jenie Yoonoo [2 ]
Kim, Eun Hee [2 ]
Park, Joong-Yeol [1 ]
Lee, Woo Je [1 ]
Kim, Hong-Kyu [2 ]
机构
[1] Univ Ulsan, Coll Med, Dept Internal Med, Asan Med Ctr, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Dept Hlth Screening & Promot Ctr, Asan Med Ctr, Seoul, South Korea
来源
PLOS ONE | 2017年 / 12卷 / 04期
关键词
CARDIOVASCULAR-DISEASE; ALL-CAUSE; RISK; ASSOCIATION; CALCIUM; ATHEROSCLEROSIS; FRAMINGHAM; MORTALITY; DEFINITION; PREDICTION;
D O I
10.1371/journal.pone.0175762
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objectives Metabolically healthy obese (MHO) phenotype describes an obese state with a favorable metabolic profile. However, the prognosis of this subpopulation remains controversial. We aimed to examine whether MHO phenotype is associated with progression of atherosclerotic activity, reflected as the changes in coronary artery calcification (CAC) over time. If so, we sought to determine the role of fatty liver disease (FLD), the hallmark of hepatic steatosis, in this progression. Methods We enrolled 1,240 asymptomatic subjects who underwent repeated CAC score measurement during routine health examinations. CAC score progression was defined as either incident CAC in a population free of CAC at baseline, or an increase by >= 2.5 units between the baseline and final square root of CAC scores in participants with detectable CAC at baseline. Subjects were stratified by body mass index (cut-off, 25.0 kg/m(2)) and metabolic health state using Adult Treatment Panel-III criteria. FLD was assessed via ultrasonography. Results Over 2.9 years of follow-up, 25.2% of total subjects exhibited CAC score progression. The MHO phenotype was not significantly associated with CAC score progression (multivariate adjusted-odds ratio [OR], 1.45; 95% confidence interval [CI], 0.93-2.25), as compared to the metabolically healthy non-obese (MHNO) phenotype. However, subgroup analysis indicated that the MHO/FLD phenotype was significantly associated with CAC score progression (multivariate adjusted-OR, 2.37; 95% CI, 1.34-4.16), as compared to the MHNO/no FLD phenotype, whereas the MHO/no FLD phenotype was not (multivariate adjusted OR, 1.25; 95% CI, 0.71-2.24). Conclusions Obese individuals with FLD have an increased risk of atherosclerosis progression, despite their healthy metabolic profile. Preventive interventions targeting cardiometabolic risk factors should be considered in such individuals, regardless of the weight status.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Assessment of Normal Systolic Blood Pressure Maintenance with the Risk of Coronary Artery Calcification Progression in Asymptomatic Metabolically Healthy Korean Adults with Normal Weight, Overweight, and Obesity
    Won, Ki-Bum
    Choi, Su-Yeon
    Chun, Eun Ju
    Park, Sung Hak
    Sung, Jidong
    Jung, Hae Ok
    Chang, Hyuk-Jae
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (11)
  • [22] Impact of Self-Rated Health on Progression to a Metabolically Unhealthy Phenotype in Metabolically Healthy Obese and Non-Obese Individuals
    Kim, Mi-Hyun
    Chang, Yoosoo
    Jung, Hyun-Suk
    Shin, Hocheol
    Ryu, Seungho
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (01)
  • [23] Arterial stiffness, fatty liver and the presence of coronary artery calcium in a large population cohort
    Sung, Ki-Chul
    Lim, Young-Hyo
    Park, Sungha
    Kang, Seok-Min
    Park, Jeong Bae
    Kim, Byung-Jin
    Shin, Jin-Ho
    CARDIOVASCULAR DIABETOLOGY, 2013, 12
  • [24] Comparison of the effect of 'metabolically healthy but obese' and 'metabolically abnormal but not obese' phenotypes on development of diabetes and cardiovascular disease in Chinese
    Luo, Deng
    Liu, Fang
    Li, Xiaowen
    Yin, Dechao
    Lin, Ziwei
    Liu, Hui
    Hou, Xuhong
    Wang, Chen
    Jia, Weiping
    ENDOCRINE, 2015, 49 (01) : 130 - 138
  • [25] Is Coronary Artery Calcification at the Intersection of Vitamin D and Coronary Artery Disease?
    Dastani, Zari
    Richards, J. Brent
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (12) : 2329 - 2330
  • [26] Triglyceride glucose index is an independent predictor for the progression of coronary artery calcification in the absence of heavy coronary artery calcification at baseline
    Won, Ki-Bum
    Park, Eun Ji
    Han, Donghee
    Lee, Ji Hyun
    Choi, Su-Yeon
    Chun, Eun Ju
    Park, Sung Hak
    Han, Hae-Won
    Sung, Jidong
    Jung, Hae Ok
    Chang, Hyuk-Jae
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [27] Association between the Severity of Nonalcoholic Fatty Liver Disease and the Risk of Coronary Artery Calcification
    Chen, Chien-Chih
    Hsu, Wei-Chien
    Wu, Han-Ming
    Wang, Jiun-Yi
    Yang, Pei-Yu
    Lin, I-Ching
    MEDICINA-LITHUANIA, 2021, 57 (08):
  • [28] Nonalcoholic Fatty Liver Disease Is Associated With Coronary Artery Calcification Development: A Longitudinal Study
    Park, Hyo Eun
    Kwak, Min-Sun
    Kim, Donghee
    Kim, Min-Kyung
    Cha, Myung-jin
    Choi, Su-Yeon
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (08) : 3134 - 3143
  • [29] Association Between Nonalcoholic Fatty Liver Disease and Coronary Artery Calcification
    Chen, Chien-Hua
    Nien, Chiu-Kue
    Yang, Chi-Chieh
    Yeh, Yung-Hsiang
    DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (06) : 1752 - 1760
  • [30] Association of non-alcoholic fatty liver disease with coronary artery calcification progression: a systematic review and meta-analysis
    Koulaouzidis, George
    Charisopoulou, Dafni
    Kukla, Michal
    Marlicz, Wojciech
    Rydzewska, Grazyna
    Koulaouzidis, Anastasios
    Skonieczna-Zydecka, Karolina
    GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, 2021, 16 (03): : 196 - 206